Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP552717.RALncDUocwOrYx1g6Xk-YIlwPmILgltiAZneUH1TuQ3sQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP552717.RALncDUocwOrYx1g6Xk-YIlwPmILgltiAZneUH1TuQ3sQ130_assertion type Assertion NP552717.RALncDUocwOrYx1g6Xk-YIlwPmILgltiAZneUH1TuQ3sQ130_head.
- NP552717.RALncDUocwOrYx1g6Xk-YIlwPmILgltiAZneUH1TuQ3sQ130_assertion description "[In multivariate analysis of all patients and those with advanced disease, serum trypsin-2-API concentration was an adverse prognostic factor for cancer-specific and progression-free survival, and it was independent of stage and histological type of the tumor (P <or= 0.01).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP552717.RALncDUocwOrYx1g6Xk-YIlwPmILgltiAZneUH1TuQ3sQ130_provenance.
- NP552717.RALncDUocwOrYx1g6Xk-YIlwPmILgltiAZneUH1TuQ3sQ130_assertion evidence source_evidence_literature NP552717.RALncDUocwOrYx1g6Xk-YIlwPmILgltiAZneUH1TuQ3sQ130_provenance.
- NP552717.RALncDUocwOrYx1g6Xk-YIlwPmILgltiAZneUH1TuQ3sQ130_assertion SIO_000772 15269150 NP552717.RALncDUocwOrYx1g6Xk-YIlwPmILgltiAZneUH1TuQ3sQ130_provenance.
- NP552717.RALncDUocwOrYx1g6Xk-YIlwPmILgltiAZneUH1TuQ3sQ130_assertion wasDerivedFrom befree-20140225 NP552717.RALncDUocwOrYx1g6Xk-YIlwPmILgltiAZneUH1TuQ3sQ130_provenance.
- NP552717.RALncDUocwOrYx1g6Xk-YIlwPmILgltiAZneUH1TuQ3sQ130_assertion wasGeneratedBy ECO_0000203 NP552717.RALncDUocwOrYx1g6Xk-YIlwPmILgltiAZneUH1TuQ3sQ130_provenance.